Modulation of amino acid metabolic signatures by supplemented isoenergetic diets differing in protein and cereal fiber content

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages E2599-E2609

  Hattersley, John G ^a,b   Pfeiffer, Andreas F H ^c,d   Roden, Michael ^e,f   Petzke, Klaus Jürgen ^c   Hoffmann, Daniela ^c,d   Rudovich, Natalia N ^c,d   Randeva, Harpal S ^a,b   Vatish, Manu ^g   Osterhoff, Martin ^c,d   Goegebakan, Özlem ^c,d   Hornemann, Silke ^c,d   Nowotny, Peter ^e,f   Machann, Jürgen ^h   Hierholzer, Johannes ^d   Von Loeffelholz, Christian ⁱ   Möhlig, Matthias ^c,d   Arafat, Ayman M ^c,d   Weickert, Martin O ^a,b,c,d  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h UNIVERSITY OF TÜBINGEN   (Germany)

ⁱ JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BRANCHED CHAIN AMINO ACID; TRYPTOPHAN; FAT; PROTEIN INTAKE;

ADULT; AMINO ACID METABOLISM; ARTICLE; BODY FAT; CEREAL; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DIETARY INTAKE; FAT MASS; FEMALE; FOOD COMPOSITION; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; ISOENERGETIC DIET; LIVER; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL; BLOOD; BODY COMPOSITION; CHEMISTRY; DIET THERAPY; DIETARY FIBER; DRUG EFFECTS; LOW CALORY DIET; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PHARMACOLOGY; PROTEIN INTAKE;

AMINO ACIDS; BODY COMPOSITION; CEREALS; DIET, REDUCING; DIETARY FIBER; DIETARY PROTEINS; FATS; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT;

EID: 84916641637     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2302     Document Type: Article

References (29)

1. Langenberg C, Savage DB. An amino acid profile to predict diabetes? Nat Med. 2011;17(4):418-420.
2. Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012;15(5):606-614.
3. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448-453.
4. Brancati FL, Wang NY, Mead LA, Liang KY, Klag MJ. Body weight patterns from 20 to 49 years of age and subsequent risk for diabetes mellitus: the Johns Hopkins Precursors Study. Arch Intern Med. 1999;159(9):957-963.
5. Felig P, Marliss E, Cahill GF, Jr. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med. 1969;281(15):811-816.
6. Breum L, Rasmussen MH, Hilsted J, Fernstrom JD. Twenty-four-hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am J Clin Nutr. 2003;77(5):1112-1118.
7. Gatti E, Porrini M, Noè D, Crovetti R, Testolin G. Plasma amino acids changes in obese patients on very low-calorie diets. Int J Vitam Nutr Res. 1994;64(1):81-85.
8. Krebs M, Krssak M, Bernroider E, et al. Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes. 2002;51(3):599-605.
9. Tremblay F, Krebs M, Dombrowski L, et al. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes. 2005;54(9):2674-2684.
10. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9(4):311-326.
11. Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R. Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr. 2005;82(2):355-365.
12. Weickert MO, Roden M, Isken F, et al. Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr. 2011;94(2):459-471.
13. Machann J, Thamer C, Stefan N, et al. Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. Radiology. 2010;257(2):353-363.
14. Hattersley JG, Mohlig M, Roden M, et al. Quantifying the improvement of surrogate indices of hepatic insulin resistance using complex measurement techniques. PLoS One. 2012;7(6):e39029.
15. Moore S, Spackman DH, Stein WH. Automatic recording apparatus for use in the chromatography of amino acids. Fed Proc. 1958;17(4):1107-1115.
16. Petzke KJ, Schuppe S, Rohn S, Rawel HM, Kroll J. Chlorogenic acid moderately decreases the quality of whey proteins in rats. J Agric Food Chem. 2005;53(9):3714-3720.
17. Larsen TM, Dalskov SM, van Baak M, et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med. 2010;363(22):2102-2113.
18. Felig P, Owen OE, Wahren J, Cahill GF, Jr. Amino acid metabolism during prolonged starvation. J Clin Invest. 1969;48(3):584-594.
19. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288(2):E462-E468.
20. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487-1495.
21. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med. 2007;4(8):e261.
22. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med. 2007;167(9):956-965.
23. Weickert MO, Arafat AM, Blaut M, et al. Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity. Nutr Metab (Lond). 2011;8:90.
24. Layman DK, Walker DA. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr. 2006;136(1 Suppl):319S-323S.
25. She P, Reid TM, Bronson SK, et al. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. 2007;6(3):181-194.
26. Lackey DE, Lynch CJ, Olson KC, et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab. 2013;304(11):E1175-E1187.
27. Cota D, Proulx K, Smith KA, et al. Hypothalamic mTOR signaling regulates food intake. Science. 2006;312(5775):927-930.
28. Koopman R, Walrand S, Beelen M, et al. Dietary protein digestion and absorption rates and the subsequent postprandial muscle protein synthetic response do not differ between young and elderly men. J Nutr. 2009;139(9):1707-1713.
29. Geypens B, Claus D, Evenepoel P, et al. Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. Gut. 1997;41(1):70-76.